ロード中...
Concerns Regarding the Use of Dabigatran for Stroke Prevention in Atrial Fibrillation
Dabigatran is an oral thrombin inhibitor which has been approved in several countries as an alternative to vitamin-K-antagonists for the prevention of stroke or embolism in atrial fibrillation patients. Dabigatran is introduced into clinical practice, although many issues regarding this drug are sti...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3763635/ https://ncbi.nlm.nih.gov/pubmed/24288086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph5020155 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|